Minimum information about a bioactive entity (MIABE) (original) (raw)

References

  1. Hopkins, A. L. & Groom, C. R. The druggable genome. Nature Rev. Drug Discov. 1, 727–730 (2002).
    Article CAS Google Scholar
  2. Hajduk, P. J., Huth, J. R., & Tse, C. Predicting protein druggability. Drug Discov. Today 10, 1675–1682 (2005).
    Article CAS Google Scholar
  3. Schmidtke, P. & Barril, X. Understanding and predicting druggability. A high-throughput method for detection of drug binding sites. J. Med. Chem. 53, 5858–5867 (2010).
    Article CAS Google Scholar
  4. Halgren, T. A. Identifying and characterizing binding sites and assessing druggability. J. Chem. Inf. Model. 49, 377–389 (2009).
    Article CAS Google Scholar
  5. Zhang, Z. & Grigorov, M. G. Similarity networks of protein binding sites. Proteins 62, 470–478 (2006).
    Article CAS Google Scholar
  6. Overington, J. P., Al-Lazikani, B. & Hopkins, A. L. How many drug targets are there? Nature Rev. Drug Discov. 5, 993–996 (2006).
    Article CAS Google Scholar
  7. The UniProt Consortium. Ongoing and future developments at the Universal Protein Resource. Nucleic Acids Res. 39, D214–D219 (2010).
  8. Berriman, M. et al. The genome of the blood fluke Schistosoma mansoni. Nature 460, 352–358 (2009).
    Article CAS Google Scholar
  9. Brazma, A. et al. Minimum information about a microarray experiment (MIAME) — toward standards for microarray data. Nature Genet. 29, 365–371 (2001).
    Article CAS Google Scholar
  10. Degtyarenko, K. et al. ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350 (2008).
    Article CAS Google Scholar
  11. Sayers, E. W. et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 39, D38–D51 (2011).
    Article CAS Google Scholar
  12. Seiler, K. P. et al. ChemBank: a small-molecule screening and cheminformatics resource database. Nucleic Acids Res. 36, D351–D359 (2008).
    Article CAS Google Scholar
  13. Pederson, F., de Brujin, J., Munn, S. & van Leeuwen, K. Assessment of additional testing needs under REACH. Effects of (Q)SAR, risk based testing and voluntary industry activity. European Commission report EUR 20863 (2003).
  14. Vizcaino, J. A., Martens, L., Hermjakob, H., Julian, R. K. & Paton, N. W. The PSI formal document process and its implementation on the PSI website. Proteomics 7, 2355–2357 (2007).
    Article CAS Google Scholar
  15. Yeung, B. K. et al. Spirotetrahydro β-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malaria. J. Med. Chem. 53, 5155–5164 (2010).
    Article CAS Google Scholar
  16. Kerrien, S. et al. Broadening the horizon — level 2.5 of the HUPO-PSI format for molecular interactions. BMC Biol. 5, 44 (2007).
    Article Google Scholar
  17. Aranda, B. et al. PSICQUIC and PSISCORE: accessing and scoring molecular interactions. Nature Methods 8, 528–529 (2011).
    Article CAS Google Scholar
  18. Croft, D. et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 39, D691–D697 (2011).
    Article CAS Google Scholar
  19. Taylor, C. F. et al. Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project. Nature Biotech. 26, 889–896 (2008).
    Article CAS Google Scholar
  20. Orchard, S. et al. The minimum information required for reporting a molecular interaction experiment (MIMIx). Nature Biotech. 25, 894–898 (2007).
    Article CAS Google Scholar
  21. Bourbeillon, J. et al. Minimum Information about a protein affinity reagent (MIAPAR). Nature Biotech. 28, 650–653 (2010).
    Article CAS Google Scholar
  22. Schuffenhauer, A. et al. An ontology for pharmaceutical ligands and its application for in silico screening and library design. J. Chem. Inf. Comput. Sci. 42, 947–955 (2002).
    Article CAS Google Scholar
  23. Qi, D. et al. An ontology for description of drug discovery investigations. J. Integr. Bioinform. 25 Mar 2010 (doi:10.2390/biecoll-jib-2010-126).
  24. Weininger, D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem. Inf. Comput. Sci. 28, 31–36 (1988).
    Article CAS Google Scholar
  25. Stein, S. E., Heller, S. R. & Tchekhovskoi, D. An open standard for chemical structure representation: the IUPAC chemical identifier. Proceedings of the 2003 International Chemical Information Conference (Nîmes), Infonortics, 131–143 (2003).
  26. Inglese, J., Shamu, C. E. & Guy, R. K. Reporting data from high-throughput screening of small-molecule libraries. Nature Chem. Biol. 3, 438–441 (2007).
    Article CAS Google Scholar
  27. Gene Ontology Consortium. The Gene Ontology in 2010: extensions and refinements. Nucleic Acids Res. 38, D331–D335 (2010).

Download references

Acknowledgements

This work has, in part, been funded by the European Commission under the Proteomics Standards Initiative and International Molecular Exchange (PSIMEx), contract number FP7-HEALTH-2007-223411.

Author information

Authors and Affiliations

  1. Sandra Orchard, Dominic Clark, Anna Gaulton, Christoph Steinbeck, Henning Hermjakob, John Overington and Janet Thornton are at the European Molecular Biology Laboratory (EMBL)-European Bioinformatics Institute, Wellcome Trust Genome Campus, Cambridge CB10 1SD, UK.,
    Sandra Orchard, Dominic Clark, Anna Gaulton, Christoph Steinbeck, Henning Hermjakob, John Overington & Janet Thornton
  2. Bissan Al-Lazikani is at the Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, 15 Cotswold Road, Belmont, Surrey SM2 5NG, UK.,
    Bissan Al-Lazikani
  3. Steve Bryant is at the National Center for Biotechnology Information, National Library of Medicine, US National Institutes of Health, Bldg. 38A, 8600 Rockville Pike, Bethesda, Maryland 20894, USA.,
    Steve Bryant
  4. Elizabeth Calder, Ian Dix and Nick Lynch are at AstraZeneca R&D, R&D Information, Alderley Park, Macclesfield SK10 4TG, UK.,
    Elizabeth Calder, Ian Dix & Nick Lynch
  5. Ola Engkvist is at DECS Computational Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden.,
    Ola Engkvist
  6. Mark Forster is at Syngenta R&D Information Systems, International Research Centre, Jealott's Hill, Bracknell, Berkshire RG42 6EY, UK.,
    Mark Forster
  7. Michael Gilson is at the University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California 92093, USA.,
    Michael Gilson
  8. Robert Glen and Peter Murray-Rust are at the Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK.,
    Robert Glen & Peter Murray-Rust
  9. Martin Grigorov and Elena Lo Piparo are at the Nestlé Research Center, PO BOX 44, CH-1000 Lausanne 26, Switzerland.,
    Martin Grigorov & Elena Lo Piparo
  10. Kim Hammond-Kosack is at Rothamsted Research, Harpenden, Hertfordshire, AL5 2JQ, UK.,
    Kim Hammond-Kosack
  11. Lee Harland is at Pfizer, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK.,
    Lee Harland
  12. Lee Harland is also at Connected Discovery Ltd, 27 Old Gloucester Street, London WC1N 3AX, UK.,
    Lee Harland
  13. Andrew Hopkins is at Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee, Dundee DD1 5EH, UK.,
    Andrew Hopkins
  14. Christopher Larminie and Romeena K. Mann are at GlaxoSmithKline, Stevenage, Hertfordshire, SG1 2NY, UK.,
    Christopher Larminie & Romeena K. Mann
  15. Christopher Southan is at ChrisDS Consulting, Göteborg, 42166, Sweden.,
    Christopher Southan
  16. David Wishart is at the Departments of Computing Science & Biological Sciences, University of Alberta, Edmonton, Alberta T6G 2E9, Canada.,
    David Wishart

Authors

  1. Sandra Orchard
    You can also search for this author inPubMed Google Scholar
  2. Bissan Al-Lazikani
    You can also search for this author inPubMed Google Scholar
  3. Steve Bryant
    You can also search for this author inPubMed Google Scholar
  4. Dominic Clark
    You can also search for this author inPubMed Google Scholar
  5. Elizabeth Calder
    You can also search for this author inPubMed Google Scholar
  6. Ian Dix
    You can also search for this author inPubMed Google Scholar
  7. Ola Engkvist
    You can also search for this author inPubMed Google Scholar
  8. Mark Forster
    You can also search for this author inPubMed Google Scholar
  9. Anna Gaulton
    You can also search for this author inPubMed Google Scholar
  10. Michael Gilson
    You can also search for this author inPubMed Google Scholar
  11. Robert Glen
    You can also search for this author inPubMed Google Scholar
  12. Martin Grigorov
    You can also search for this author inPubMed Google Scholar
  13. Kim Hammond-Kosack
    You can also search for this author inPubMed Google Scholar
  14. Lee Harland
    You can also search for this author inPubMed Google Scholar
  15. Andrew Hopkins
    You can also search for this author inPubMed Google Scholar
  16. Christopher Larminie
    You can also search for this author inPubMed Google Scholar
  17. Nick Lynch
    You can also search for this author inPubMed Google Scholar
  18. Romeena K. Mann
    You can also search for this author inPubMed Google Scholar
  19. Peter Murray-Rust
    You can also search for this author inPubMed Google Scholar
  20. Elena Lo Piparo
    You can also search for this author inPubMed Google Scholar
  21. Christopher Southan
    You can also search for this author inPubMed Google Scholar
  22. Christoph Steinbeck
    You can also search for this author inPubMed Google Scholar
  23. David Wishart
    You can also search for this author inPubMed Google Scholar
  24. Henning Hermjakob
    You can also search for this author inPubMed Google Scholar
  25. John Overington
    You can also search for this author inPubMed Google Scholar
  26. Janet Thornton
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toSandra Orchard.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

About this article

Cite this article

Orchard, S., Al-Lazikani, B., Bryant, S. et al. Minimum information about a bioactive entity (MIABE).Nat Rev Drug Discov 10, 661–669 (2011). https://doi.org/10.1038/nrd3503

Download citation